-
Learn & Journey: ANH events (week 16/2024)
18 April 2024
Upcoming events, conferences, available courses and replays
-
NEW CAMPAIGN! Help stop Big Tech censorship of natural health
18 April 2024
ANH launches global petition to curb YouTube’s censorship based on its defective view of ‘medical misinformation’.
-
ANH News Beat (week 17/2024)
25 April 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week censorship by YouTube and X; Sign our FreeSpeech4Health petition; Hyperbaric oxygen therapy for cancer patients; American Diabetes Association conflicts of interest; ANH-USA update; covid news and more...
-
Learn & Journey: ANH events (week 15/2024)
11 April 2024
Upcoming events, conferences, available courses and replays
-
ANH News Beat (week 13/2024)
27 March 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week the nutritional importance of meat in our diet; Vaping causes cellular DNA changes; Fermed food products tsunami; UK smart meter woes; Fertility rates dropping rapidly globally; Covid news; Updates from the ANH-USA team plus more...
-
FEATURE: Dismantling the unsafe vaccine for fake news
16 May 2024
It’s already out there, it’s misleading, and may cause harm to you and others.
-
ANH News Beat (week 12/2024)
21 March 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week Big Pharma profits from obesity; Intermittent fasting - healthful or not?; Mobile phones & brain cancer; HPV vaccines & autoimmunity; Lab-grown pet food; Covid news; ANH-USA updates plus more...
-
FEATURE: Landmark US lawsuit exposes US government coercion of Big Social
02 May 2024
Gen up on Murthy v Missouri and learn why you should sign the FreeSpeech4Health petition
-
Pathfinder Members' Briefing and Q&A - March 2024
21 March 2024
Recording of March's Members' Briefing and Q&A
-
Pathfinder Members' Briefing and Q&A - March 2024
21 March 2024
Recording of March's Members' Briefing and Q&A